The Relevance of Caenorhabditis elegans Genetics for Understanding Human Psychiatric Disease

REFERENCES

• Fauci AS, Braunwald E, Kasper DL, , eds. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill Medical, 2008.
   Google Scholar
• Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974;77:71–94.
   PubMed Web of Science ®Google Scholar
• Bargmann CI. Neurobiology of the Caenorhabditis elegans genome. Science 1998;282:2028–33.
   PubMed Web of Science ®Google Scholar
• Benes FM, Lim B, Matzilevich D, Subburaju S, Walsh JP. Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci U S A 2008;105:20935–40.
   PubMed Web of Science ®Google Scholar
• Jin Y, Jorgensen E, Hartwieg E, Horvitz HR. The Caenorhabditis elegans gene unc-25 encodes glutamic acid decarboxylase and is required for synaptic transmission but not synaptic development. J Neurosci 1999;19:539–48.
   PubMed Web of Science ®Google Scholar
• Bamber BA, Beg AA, Twyman RE, Jorgensen EM. The Caenorhabditis elegans unc-49 locus encodes multiple subunits of a heteromultimeric GABA receptor. J Neurosci 1999;19:5348–59.
   PubMedGoogle Scholar
• Dittman JS, Kaplan JM. Behavioral impact of neurotransmitter-activated G-protein–coupled receptors: muscarinic and GABAB receptors regulate Caenorhabditis elegans locomotion. J Neurosci 2008;28:7104–12.
   PubMedGoogle Scholar
• Beg AA, Jorgensen EM. EXP-1 is an excitatory GABA-gated cation channel. Nat Neurosci 2003;6:1145–52.
   PubMedGoogle Scholar
• McIntire SL, Reimer RJ, Schuske K, Edwards RH, Jorgensen EM. Identification and characterization of the vesicular GABA transporter. Nature 1997;389:870–6.
   PubMed Web of Science ®Google Scholar
• White JG, Southgate, E, Thomson, JN, Brenner, S. The structure of the nervous system of the nematode Caenorhabditis elegans. Philos Trans Royal Soc London Series B, Biol Science 1986;314:1–340.
   PubMed Web of Science ®Google Scholar
• Trent C, Tsuing N, Horvitz HR. Egg-laying defective mutants of the nematode Caenorhabditis elegans. Genetics 1983;104:619–47.
   PubMed Web of Science ®Google Scholar
• Horvitz HR, Sternberg PW. Multiple intercellular signalling systems control the development of the Caenorhabditis elegans vulva. Nature 1991;351:535–41.
   PubMedGoogle Scholar
• Silva AJ, Elgersma Y, Costa RM. Molecular and cellular mechanisms of cognitive function: implications for psychiatric disorders. Biol Psychiatry 2000;47:200–9.
   PubMedGoogle Scholar
• Horvitz HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res 1999;59:1701s–6s.
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806–11.
   PubMed Web of Science ®Google Scholar
• Guarnieri DJ, DiLeone RJ. MicroRNAs: a new class of gene regulators. Ann Med 2008;40:197–208.
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843–54.
   PubMed Web of Science ®Google Scholar
• Reinhart BJ, Slack FJ, Basson M, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000;403:901–6.
   PubMed Web of Science ®Google Scholar
• Hansen T, Olsen L, Lindow M, Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2007;2:e873.
   PubMed Web of Science ®Google Scholar
• Levitan D, Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995;377:351–4.
   PubMed Web of Science ®Google Scholar
• Struhl G, Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 1999;398:522–5.
   PubMed Web of Science ®Google Scholar
• De Strooper B. Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex. Neuron 2003;38:9–12.
   PubMed Web of Science ®Google Scholar
• Kopan R, Ilagan MX. Gamma-secretase: proteasome of the membrane? Nat Rev Mol Cell Biol 2004;5:499–504.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ, Wolfe MS. Presenilin: running with scissors in the membrane. Cell 2007;131:215–21.
   PubMed Web of Science ®Google Scholar
• Carlezon WA, Jr., Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci 2005;28:436–45.
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Hughes HB 3rd, Stiffler JS, Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatry 2003;8:611–8.
   PubMed Web of Science ®Google Scholar
• Zhang X, Gainetdinov RR, Beaulieu JM, Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005;45:11–6.
   PubMed Web of Science ®Google Scholar
• Blendy JA. The role of CREB in depression and antidepressant treatment. Biol Psychiatry 2006;59:1144–50.
   PubMed Web of Science ®Google Scholar
• Sze JY, Victor M, Loer C, Shi Y, Ruvkun G. Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 2000;403:560–4.
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Jones ML, Estevez AO, Hughes HB 3rd, Estevez M. Identification of a CREB-dependent serotonergic pathway and neuronal circuit regulating foraging behavior in Caenorhabditis elegans: a useful model for mental disorders and their treatments? Am J Med Genet B Neuropsychiatr Genet 2009;150B:12–23.
   PubMed Web of Science ®Google Scholar
• Jamain S, Quach H, Betancur C, Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003;34:27–9.
   PubMed Web of Science ®Google Scholar
• Szatmari P, Paterson AD, Zwaigenbaum L, Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007;39:319–28.
   PubMed Web of Science ®Google Scholar
• Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008;9:341–55.
   PubMed Web of Science ®Google Scholar
• Kirov G, Gumus D, Chen W, Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 2008;17:458–65.
   PubMed Web of Science ®Google Scholar
• Walsh T, McClellan JM, McCarthy SE, Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008;320:539–43.
   PubMed Web of Science ®Google Scholar
• Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008;455:903–11.
   PubMed Web of Science ®Google Scholar
• Calahorro F, Alejandre E, Ruiz-Rubio M. Osmotic avoidance in Caenorhabditis elegans: synaptic function of two genes, orthologues of human NRXN1 and NLGN1, as candidates for autism. In: J Vis Exp; 2009; Dec 11. http://www.jove.com/Details.stp?ID =1616
   PubMedGoogle Scholar
• Hunter JW, Mullen GP, McManus JR, Heatherly JM, Duke A, Rand JB. Neuroligin-deficient mutants of C. elegans have sensory processing deficits and are hypersensitive to oxidative stress and mercury toxicity. Dis Model Mech 2010;3:366–76.
   PubMed Web of Science ®Google Scholar
• Feng Z, Li W, Ward A, A C. elegans model of nicotine-dependent behavior: regulation by TRP-family channels. Cell 2006;127:621–33.
   PubMed Web of Science ®Google Scholar
• Ward A, Walker VJ, Feng Z, Xu XZ. Cocaine modulates locomotion behavior in C. elegans. PLoS One 2009;4:e5946.
   Google Scholar
• Davies AG, Pierce-Shimomura JT, Kim H, A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans. Cell 2003;115:655–66.
   PubMed Web of Science ®Google Scholar
• Davies AG, Bettinger JC, Thiele TR, Judy ME, McIntire SL. Natural variation in the npr-1 gene modifies ethanol responses of wild strains of C. elegans. Neuron 2004;42:731–43.
   PubMed Web of Science ®Google Scholar
• Kapfhamer D, Bettinger JC, Davies AG, Loss of RAB-3/A in Caenorhabditis elegans and the mouse affects behavioral response to ethanol. Genes Brain Behav 2008;7:669–76.
   PubMedGoogle Scholar
• Dempsey CM, Mackenzie SM, Gargus A, Blanco G, Sze JY. Serotonin (5HT), fluoxetine, imipramine and dopamine target distinct 5HT receptor signaling to modulate Caenorhabditis elegans egg-laying behavior. Genetics 2005;169:1425–36.
   PubMed Web of Science ®Google Scholar
• Karmacharya R, Sliwoski GR, Lundy MY, Suckow RF, Cohen BM, Buttner EA. Clozapine interaction with phosphatidyl inositol 3-kinase (PI3K)/insulin-signaling pathway in Caenorhabditis elegans. Neuropsychopharmacology 2009;34:1968–78.
   PubMedGoogle Scholar
• Donohoe DR, Phan T, Weeks K, Aamodt EJ, Dwyer DS. Antipsychotic drugs up-regulate tryptophan hydroxylase in ADF neurons of Caenorhabditis elegans: role of calcium-calmodulin-dependent protein kinase II and transient receptor potential vanilloid channel. J Neurosci Res 2008;86:2553–63.
   PubMedGoogle Scholar
• Donohoe DR, Jarvis RA, Weeks K, Aamodt EJ, Dwyer DS. Behavioral adaptation in C. elegans produced by antipsychotic drugs requires serotonin and is associated with calcium signaling and calcineurin inhibition. Neurosci Res 2009;64:280–9.
   PubMedGoogle Scholar
• Evason K, Collins JJ, Huang C, Hughes S, Kornfeld K. Valproic acid extends Caenorhabditis elegans lifespan. Aging Cell 2008;7:305–17.
   PubMed Web of Science ®Google Scholar
• Tokuoka SM, Saiardi A, Nurrish SJ. The mood stabilizer valproate inhibits both inositol- and diacylglycerol-signaling pathways in Caenorhabditis elegans. Mol Biol Cell 2008;19:2241–50.
   PubMedGoogle Scholar
• Choy RK, Thomas JH. Fluoxetine-resistant mutants in C. elegans define a novel family of transmembrane proteins. Mol Cell 1999;4:143–52.
   PubMed Web of Science ®Google Scholar
• Choy RK, Kemner JM, Thomas JH. Fluoxetine-resistance genes in Caenorhabditis elegans function in the intestine and may act in drug transport. Genetics 2006;172:885–92.
   PubMedGoogle Scholar
• Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789–96.
   PubMed Web of Science ®Google Scholar
• Kumra S, Kranzler H, Gerbino-Rosen G, Clozapine and “high-dose” olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. Biol Psychiatry 2008;63:524–9.
   PubMed Web of Science ®Google Scholar
• Krupp P, Barnes P. Clozapine-associated agranulocytosis: risk and aetiology. Br J Psychiatry Suppl 1992: May;38–40.
   PubMedGoogle Scholar
• Meltzer HY. What's atypical about atypical antipsychotic drugs? Curr Opin Pharmacol 2004;4:53–7.
   PubMed Web of Science ®Google Scholar
• Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 1996;93:8455–9.
   PubMed Web of Science ®Google Scholar
• Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 1997;185:82–91.
   PubMed Web of Science ®Google Scholar
• Gould TD, Einat H, O'Donnell KC, Picchini AM, Schloesser RJ, Manji HK. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 2007;32:2173–83.
   PubMedGoogle Scholar
• Weeks KR, Dwyer DS, Aamodt EJ. Antipsychotic drugs activate the C. elegans Akt pathway via the DAF-2 insulin/IGF-1 receptor. ACS Chem Neurosci 2010;1:463–73.
   PubMedGoogle Scholar
• Kalkman HO. The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol Ther 2006;110:117–34.
   PubMed Web of Science ®Google Scholar
• Kim M, Hersh LB, Leissring MA, Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families. J Biol Chem 2007;282:7825–32.
   PubMed Web of Science ®Google Scholar
• Girgis RR, Javitch JA, Lieberman JA. Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway. Mol Psychiatry 2008;13:918–29.
   PubMed Web of Science ®Google Scholar
• Moy TI, Conery AL, Larkins-Ford J, High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol 2009;4:527–33.
   PubMed Web of Science ®Google Scholar
• Best JD, Alderton WK. Zebrafish: an in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat 2008;4:567–76.
   PubMedGoogle Scholar
• Lam SH, Mathavan S, Tong Y, Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical biology. PLoS Genet 2008;4: e1000121.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Stroup TS, McEvoy JP, Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209–23.
   PubMed Web of Science ®Google Scholar
• Swartz MS, Perkins DO, Stroup TS, Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Am J Psychiatry 2007;164:428–36.
   PubMed Web of Science ®Google Scholar
• Gray JA, Roth BL. The pipeline and future of drug development in schizophrenia. Mol Psychiatry 2007;12:904–22.
   PubMed Web of Science ®Google Scholar
• Santarelli L, Saxe M, Gross C, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805–9.
   PubMed Web of Science ®Google Scholar
• Ahringer J. Turn to the worm! Curr Opin Genet Dev 1997;7:410–5.
   PubMedGoogle Scholar